I

f you’re having trouble keeping track of all those cancer moonshots, take note: One of them just changed its name after being sued over it.

That’s the initiative launched as “Cancer MoonShot 2020” a year ago with a mission of teaming up different companies to test dozens of new immunotherapy drugs for cancer in various combinations. The project’s leader is the brash biotech billionaire Dr. Patrick Soon-Shiong, who is now being considered for a senior role in the Trump administration overseeing health care.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy